STOCK TITAN

Bioceres Crop Solutions (BIOX) Stock News

BIOX Nasdaq

Welcome to our dedicated page for Bioceres Crop Solutions news (Ticker: BIOX), a resource for investors and traders seeking the latest updates and insights on Bioceres Crop Solutions stock.

Bioceres Crop Solutions Corp. reports developments tied to crop productivity technologies for agricultural markets, including seeds, seed traits, seed treatments, biologicals, adjuvants, fertilizers, crop protection products and crop nutrition. Its recurring updates focus on operating results across crop protection, seed and integrated products, and crop nutrition, with frequent discussion of product mix, margins, working-capital discipline and conditions in Argentina.

Bioceres also announces collaboration and commercialization activity for HB4 wheat, a trait platform positioned for climate-resilient wheat production, as well as updates on capital structure matters and asset-related disputes affecting the business. Bioceres presents financial results under IFRS and regularly schedules calls around quarterly and full-year reporting periods.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.05%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.98%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.09%
Tags
conferences earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.73%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.14%
Tags
Rhea-AI Summary

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced a conference call scheduled for May 11, 2023, at 8:30 a.m. ET to discuss its financial results for the third quarter ended March 31, 2023. The call will be hosted by key executives, including CEO Federico Trucco and CFO Enrique Lopez Lecube, and will include a presentation accessible via the company's investor relations website. Investors can participate using a toll-free number or through an international dial-in link. A replay of the call will be available until May 18, 2023. Bioceres is focused on crop productivity solutions aimed at promoting carbon neutrality in agriculture, leveraging its unique biotech platform and the HB4 program for enhanced farmer support and output traceability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.65%
Tags
none
-
Rhea-AI Summary

Arcadia Biosciences reported a remarkable 47% increase in total revenues for 2022, reaching $9.96 million, driven by strong sales of GoodWheat pasta and coconut water. Operating expenses declined by 32% to $28.8 million, significantly reducing cash burn. The launch of GoodWheat pasta exceeded expectations, distributing in over 1,200 stores within seven months. The company also unveiled Project Greenfield, a three-year plan to enhance profitability and product expansion. Despite the progress, net losses for the year increased to $15.4 million, highlighting ongoing challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.35%
Tags
Rhea-AI Summary

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) will participate in the 35th Annual Roth Conference from March 12-14, 2023, at The Ritz Carlton Laguna Niguel in Dana Point, California. CEO Federico Trucco and CFO Enrique Lopez Lecube will attend to discuss the recent fiscal second quarter 2023 financial results, HB4 Wheat 2022/23 results, and regulatory approvals. Trucco will also join the 'AG Biologicals and Gene Editing' panel on March 13 at 1:30 PM PT. For more details, visit the Roth Conference website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.77%
Tags
conferences

FAQ

What is the current stock price of Bioceres Crop Solutions (BIOX)?

The current stock price of Bioceres Crop Solutions (BIOX) is $0.3804 as of June 19, 2026.

What is the market cap of Bioceres Crop Solutions (BIOX)?

The market cap of Bioceres Crop Solutions (BIOX) is approximately 23.8M.